Provided by Tiger Trade Technology Pte. Ltd.

2Seventy Bio Inc

5.00
0.0000
Volume:- -
Turnover:5.78M
Market Cap:266.15M
PE:-63.66
High:5.00
Open:5.00
Low:5.00
Close:5.00
52wk High:5.30
52wk Low:2.29
Shares:53.23M
Float Shares:42.70M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0785
EPS(LYR):-1.0963
ROE:-1.94%
ROA:-7.49%
PB:1.24
PE(LYR):-4.56

Loading ...

Company Profile

Company Name:
2Seventy Bio Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.